[go: up one dir, main page]

FI20010214L - Asyyliaminoindolijohdannaisia - Google Patents

Asyyliaminoindolijohdannaisia Download PDF

Info

Publication number
FI20010214L
FI20010214L FI20010214A FI20010214A FI20010214L FI 20010214 L FI20010214 L FI 20010214L FI 20010214 A FI20010214 A FI 20010214A FI 20010214 A FI20010214 A FI 20010214A FI 20010214 L FI20010214 L FI 20010214L
Authority
FI
Finland
Prior art keywords
acylaminoindole
derivatives
acylaminoindole derivatives
Prior art date
Application number
FI20010214A
Other languages
English (en)
Swedish (sv)
Inventor
John E Macor
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI20010214L publication Critical patent/FI20010214L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Soft Magnetic Materials (AREA)
  • Supply Devices, Intensifiers, Converters, And Telemotors (AREA)
  • Pyrrole Compounds (AREA)
FI20010214A 1992-04-10 2001-02-05 Asyyliaminoindolijohdannaisia FI20010214L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86638292A 1992-04-10 1992-04-10

Publications (1)

Publication Number Publication Date
FI20010214L true FI20010214L (fi) 2001-02-05

Family

ID=25347493

Family Applications (2)

Application Number Title Priority Date Filing Date
FI931613A FI111256B (fi) 1992-04-10 1993-04-08 Menetelmä terapeuttisesti käyttökelpoisten asyyliaminoindolijohdannaisten valmistamiseksi
FI20010214A FI20010214L (fi) 1992-04-10 2001-02-05 Asyyliaminoindolijohdannaisia

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI931613A FI111256B (fi) 1992-04-10 1993-04-08 Menetelmä terapeuttisesti käyttökelpoisten asyyliaminoindolijohdannaisten valmistamiseksi

Country Status (31)

Country Link
US (1) US5498626A (fi)
EP (1) EP0635015B1 (fi)
JP (1) JP2544704B2 (fi)
KR (1) KR0179074B1 (fi)
CN (1) CN1038506C (fi)
AT (1) ATE148465T1 (fi)
AU (1) AU670270B2 (fi)
BR (1) BR9306221A (fi)
CA (1) CA2132706C (fi)
CZ (1) CZ282653B6 (fi)
DE (1) DE69307875T2 (fi)
DK (1) DK0635015T3 (fi)
EG (1) EG20466A (fi)
ES (1) ES2097496T3 (fi)
FI (2) FI111256B (fi)
GR (1) GR3022767T3 (fi)
HR (1) HRP930753B1 (fi)
HU (1) HUT64060A (fi)
IL (1) IL105309A0 (fi)
MX (1) MX9301996A (fi)
MY (1) MY115278A (fi)
NO (1) NO309860B1 (fi)
NZ (1) NZ251047A (fi)
PL (1) PL172232B1 (fi)
RU (1) RU2110516C1 (fi)
SK (1) SK278182B6 (fi)
TW (1) TW394769B (fi)
UA (1) UA34452C2 (fi)
WO (1) WO1993021180A1 (fi)
YU (1) YU48916B (fi)
ZA (1) ZA932536B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US6380233B1 (en) 1992-04-07 2002-04-30 Pfizer Inc Indole derivatives as 5-HT1 agonists
CA2133413C (en) 1992-04-07 2001-04-10 John Eugene Macor Indole derivatives as 5-ht1 antagonists
ES2070772B1 (es) * 1993-08-09 1996-02-16 Pfizer Derivados de acilaminoindol
CZ59996A3 (en) * 1993-08-31 1996-06-12 Pfizer 5-arylindole derivatives per se and for treating diseases, intermediates for their preparation and pharmaceutical compositions based thereon
GB9402016D0 (en) * 1994-02-02 1994-03-30 Merck Sharp & Dohme Therapeutic agents
GB9402011D0 (en) * 1994-02-02 1994-03-30 Merck Sharp & Dohme Therapeutic agents
AU3162695A (en) * 1994-08-03 1996-03-04 Asta Medica Aktiengesellschaft Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects
GB9417310D0 (en) 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9420503D0 (en) * 1994-10-11 1994-11-23 Pfizer Ltd Therapeutic agents
GB9420529D0 (en) 1994-10-12 1994-11-30 Pfizer Ltd Indoles
WO1999053956A1 (fr) * 1998-04-16 1999-10-28 Yamanouchi Pharmaceutical Co., Ltd. Remedes contre l'obesite
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
AU2004206909A1 (en) * 2003-01-22 2004-08-05 Gtx Inc. Treating androgen deficiency in female (ADIF)-associated conditions with sarms
WO2009071988A1 (en) * 2007-12-07 2009-06-11 Pfizer Inc. Tosylate salt of trans-n-isobutyl-3-fluoro-3- [3-flu0r0-4- (pyrrolidin-1-yl-methyl) -phenyl] cyclobut anecarboxamide
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
CN103408535B (zh) * 2013-08-13 2016-03-02 张家港威胜生物医药有限公司 一种依来曲普坦中间体-5-溴-3-(n-甲基吡咯啉-2-基甲基)-1h-吲哚合成工艺

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
BE889931A (fr) * 1980-08-12 1982-02-11 Glaxo Group Ltd Derives indoliques, leur preparation et leurs applications en tant que medicaments
GB2083463B (en) * 1980-08-12 1984-05-10 Glaxo Group Ltd Heterocyclic compounds
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
IL96891A0 (en) * 1990-01-17 1992-03-29 Merck Sharp & Dohme Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
CA2042295A1 (fr) * 1990-05-15 1991-11-16 Jacques Chauveau Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
IL114690A (en) * 1990-06-07 1997-02-18 Wellcome Found Antimigraine oxazolidinone substituted indole derivatives
JP2575272B2 (ja) * 1990-10-15 1997-01-22 フアイザー・インコーポレイテツド インドール誘導体
US5208248A (en) * 1991-01-11 1993-05-04 Merck Sharpe & Dohme, Ltd. Indazole-substituted five-membered heteroaromatic compounds
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
ES2143992T3 (es) * 1991-11-25 2000-06-01 Pfizer Derivados de 5-(hetero- o carbociclilamino)-indol, su preparacion y uso como 5-ht1 agonistas.

Also Published As

Publication number Publication date
HRP930753A2 (en) 1994-10-31
WO1993021180A1 (en) 1993-10-28
NZ251047A (en) 1996-09-25
FI931613A0 (fi) 1993-04-08
HRP930753B1 (en) 2000-10-31
BR9306221A (pt) 1998-06-30
MX9301996A (es) 1994-03-31
KR0179074B1 (ko) 1999-03-20
GR3022767T3 (en) 1997-06-30
NO943803L (no) 1994-10-07
NO943803D0 (no) 1994-10-07
RU94045902A (ru) 1996-08-27
PL172232B1 (pl) 1997-08-29
SK120794A3 (en) 1995-05-10
DK0635015T3 (da) 1997-03-17
EP0635015A1 (en) 1995-01-25
FI931613L (fi) 1993-10-11
TW394769B (en) 2000-06-21
HU9301048D0 (en) 1993-06-28
JP2544704B2 (ja) 1996-10-16
IL105309A0 (en) 1993-08-18
YU25593A (sh) 1996-10-09
CN1080288A (zh) 1994-01-05
ATE148465T1 (de) 1997-02-15
JPH07501831A (ja) 1995-02-23
YU48916B (sh) 2002-11-15
NO309860B1 (no) 2001-04-09
FI111256B (fi) 2003-06-30
EP0635015B1 (en) 1997-01-29
EG20466A (en) 1999-05-31
CZ247794A3 (en) 1995-07-12
AU670270B2 (en) 1996-07-11
UA34452C2 (uk) 2001-03-15
ES2097496T3 (es) 1997-04-01
RU2110516C1 (ru) 1998-05-10
KR950700903A (ko) 1995-02-20
SK278182B6 (en) 1996-03-06
CZ282653B6 (cs) 1997-08-13
ZA932536B (en) 1994-10-08
CA2132706C (en) 1998-08-04
DE69307875T2 (de) 1997-05-22
MY115278A (en) 2003-05-31
DE69307875D1 (de) 1997-03-13
US5498626A (en) 1996-03-12
HUT64060A (en) 1993-11-29
AU3782193A (en) 1993-11-18
CN1038506C (zh) 1998-05-27
CA2132706A1 (en) 1993-10-28

Similar Documents

Publication Publication Date Title
FI930208L (fi) Kinazolinderivat
FI980341L (fi) 2-oksi-indolijohdannaisia
ATA75293A (de) Indolderivate
DE69208877D1 (de) Chinuclidinderivate
FI924159L (fi) Benzanilidderivat
NO922182D0 (no) Krystallinske oksatiolan-derivater
FI935902L (fi) Ofodrad foerslutningsanordning
DE69330497D1 (de) Chinazolin-derivate
FI925763A0 (fi) Fungicida 2-imidazolin-5-on- och 2-imidazolin-5-tionderivat
FI923726L (fi) Sulfaterade glykosaminoglykanoidderivat
FI20010214L (fi) Asyyliaminoindolijohdannaisia
FI945674L (fi) Substituoidut 2beta-morfoliini-androstaanijohdannaiset
DE59308714D1 (de) Cyclobutan-benzol-derivate
FI20002460L (fi) 4-difenyylimetyylipiperidiinijohdannaisia
FI943885L (fi) Penaami-johdannaiset
AT399443B (de) Sportschuh
FI944044L (fi) Fenyylialkanoliamiinijohdannaiset
FI935243L (fi) Pyridonkarboxylsyraderivat
ATA236892A (de) Rotornut
NO952288D0 (no) Benzazepinon-derivater
DE69313890D1 (de) 5-Aminoflavon-Derivate
FI930367L (fi) Puridinderivat
FI924145L (fi) 3-cykloalkylprop-2-enamidderivat
DE59407726D1 (de) 3-Aryl-4-hydroxy-3-dihydrofuranon-Derivate
FI942070L (fi) Nitroksialkyyliamidijohdannaiset